Navigation Links
More Than 300 New Medicines Being Developed for Mental Illnesses
Date:7/24/2008

NEW ORLEANS, July 24 /PRNewswire-USNewswire/ -- There are a record 301 new medicines being developed for mental illnesses, according to a new report released here today during a briefing that focused on the devastating effects that mental illnesses have on patients, their families, and society. Nationwide, mental illness affects nearly 60 million American adults. The briefing, led by the Pharmaceutical Research and Manufacturers of America (PhRMA), featured Emmy Award-winning actor Joey Pantoliano -- well known for his role in The Sopranos -- who suffers from depression.

In Louisiana, rates of post-traumatic stress disorder and suicide have increased since hurricanes Katrina and Rita, according to the National Institute on Drug Abuse. Mental disorders after a natural disaster usually decrease with time, with about 50 percent of post-traumatic mental disorders resolved within a year of the disaster, notes a recent Harvard University study. However, in the case of Hurricane Katrina, the researchers found the contrary: Anxiety or mood disorder has been increasing by 30 percent and more.

"We are releasing this report in Louisiana in view of the upcoming third anniversary of Hurricane Katrina and the state's continuing need for assistance in treating mental illness," said PhRMA Senior Vice President Ken Johnson. "The medicines being developed treat a range of conditions, from depression to anxiety, and from schizophrenia to dependence on alcohol and drugs. These medicines are either in clinical trials or awaiting review by the U.S. Food and Drug Administration, and they will help patients live longer, happier, and healthier lives. It's important for patients and healthcare providers to know that research into mental illness remains a top priority."

Many of these diseases, such as depression, were once misunderstood causes of shame and fear. Fortunately, today many are highly treatable conditions.

Unfortunately, despite the tremendous pr
'/>"/>

SOURCE Pharmaceutical Research and Manufacturers of America
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. AstraZeneca Submits sNDA for SEROQUEL XR(TM) for the Treatment of Generalized Anxiety Disorder - a First for the Atypical Antipsychotic Class of Medicines
2. European Medicines Agency Adopts Positive Opinion for Ranolazine for Treatment of Chronic Angina
3. Report on 750 New Medicines in Development for Cancer Released in Baton Rouge
4. Pharmion and MethylGene Announce Orphan Drug Designation Granted by the European Medicines Agency (EMEA) for MGCD0103 for the Treatment of Acute Myelogenous Leukemia
5. ActivBiotics Receives Orphan Drug Designation from the European Medicines Agency for Superoxide Dismutase Mimetic, M40403, in Oral Mucositis Indication
6. Thalidomide Pharmion(R) Receives Positive Opinion for Treatment of First-line Multiple Myeloma from European Medicines Agency
7. New Report Offers Hope for Closing Health Gap for African Americans, With Nearly 700 Medicines in Pipeline
8. 92 Medicines and Vaccines now in Development for HIV/AIDS
9. Schering-Plough Announces Imperfect Contraceptive Use Impacts Womens Emotional Well-Being
10. New Data Confirms That a Selective, Fully Human Anti-VEGF Antibody Being Developed by Peregrine is as Effective as Avastin(R) in Preclinical Cancer Models
11. Plavix(R) Indications Expanded in Japan to Include Patients with Acute Coronary Syndrome for Whom Percutaneous Coronary Intervention Is Being Planned
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/5/2015)... PRINCETON, N.J. , March 5, 2015 ... late stage biopharmaceutical company committed to developing products that ... oncology and biodefense, announced today that its President and ... will give a corporate presentation at the 27 th ... California , on Tuesday, March 10, 2015 at ...
(Date:3/5/2015)... Mar. 05, 2015 Research and Markets ... "Global Rising Stars Outlook 2015" report to ... diseases are being sought after with fresh vigor as ... field which is poised to bring a paradigm change ... decades is the Stem cell therapy/Regenerative Medicine space. ...
(Date:3/5/2015)... , March 5, 2015  Asterias Biotherapeutics, Inc. (NYSE ... field of regenerative medicine, announced today that ... top rehabilitation hospitals for spinal cord injury and brain ... trial of AST-OPC1 (oligodendrocyte progenitor cells) in newly injured ... injury (SCI). The Phase 1/2a trial ...
Breaking Medicine Technology:Soligenix to Present at the 27th Annual ROTH Conference 2Soligenix to Present at the 27th Annual ROTH Conference 3Global Pharma Rising Stars Outlook 2015 2Asterias Biotherapeutics Initiates Patient Enrollment for Phase 1/2a Clinical Trial of AST-OPC1 in Newly Injured People with Complete Cervical Spinal Cord Injury 2Asterias Biotherapeutics Initiates Patient Enrollment for Phase 1/2a Clinical Trial of AST-OPC1 in Newly Injured People with Complete Cervical Spinal Cord Injury 3Asterias Biotherapeutics Initiates Patient Enrollment for Phase 1/2a Clinical Trial of AST-OPC1 in Newly Injured People with Complete Cervical Spinal Cord Injury 4
... 2011 Savient Pharmaceuticals, Inc. (NASDAQ: SVNT ) ... the third quarter 2011 prior to the open of the ... H. Johnson, Chief Executive Officer and President, and Kenneth J. ... an investment community conference call beginning at 9:00 a.m. Eastern ...
... Blood America, Inc. ( www.cordblood-america.com ) (OTC Bulletin Board: ... cell preservation company  focused on bringing the life saving ... today announced that its Board of Directors will conduct ... Cord Blood America to enhance shareholder value. ...
Cached Medicine Technology:Savient Pharmaceuticals to Hold Third Quarter 2011 Financial Results Conference Call on Thursday, November 3, 2011 2Cord Blood America, Inc. to Evaluate Possible Strategic Alternatives 2
(Date:3/5/2015)... March 05, 2015 This week, ... in low-cost laminate flooring products, initiating widespread ... of eco-friendly building materials made primarily from bamboo, ... testing all their flooring products for volatile organic ... Benchmark International (BMH). Results from formaldehyde ...
(Date:3/5/2015)... (PRWEB) March 05, 2015 AxoGen, ... focused on the peripheral nerve repair market, reported record ... December 31, 2014 compared to $2.98 million in the ... its growth strategies. , “Our strong fourth quarter ... peripheral nerve repair products which is driving increased surgeon ...
(Date:3/5/2015)... York, New York (PRWEB) March 05, 2015 ... of men who allegedly suffered heart attacks, strokes and ... prescription low testosterone therapies continue to move forward in ... Court, Northern District of Illinois. According to a Case ... set forth procedures for the use of master pleadings ...
(Date:3/5/2015)... Rhode Island Medical Imaging (RIMI) was pleased to ... support the Providence College (PC) women’s basketball program’s fight to ... the ‘Think Pink’ uniforms, which were worn during the February ... University at Alumni Hall/Mullaney Gymnasium in Providence, R.I. ... PC women’s basketball’s ‘Pink Out’ event,” said Dr. Scott Levine ...
(Date:3/5/2015)... 2015 The Maricopa Community Colleges ... to the Arizona economy each year, according to a ... Economic Value of Maricopa County Community College District, summarizes ... district in fiscal year 2013-2014. , The analysis ... (EMSI), an organization that specializes in providing economic impact ...
Breaking Medicine News(10 mins):Health News:With Homeowners Concerned About Formaldehyde, Cali Bamboo Puts Safety Above Bottom Line 2Health News:AxoGen, Inc. Reports 61% Revenue Growth for the 2014 Fourth Quarter 2Health News:AxoGen, Inc. Reports 61% Revenue Growth for the 2014 Fourth Quarter 3Health News:AxoGen, Inc. Reports 61% Revenue Growth for the 2014 Fourth Quarter 4Health News:Testosterone Lawsuits Move Forward, as Bernstein Liebhard LLP Comments on Most Recent Order Issued in Federal Litigation 2Health News:Testosterone Lawsuits Move Forward, as Bernstein Liebhard LLP Comments on Most Recent Order Issued in Federal Litigation 3Health News:Testosterone Lawsuits Move Forward, as Bernstein Liebhard LLP Comments on Most Recent Order Issued in Federal Litigation 4Health News:RIMI Teams Up with PC Women’s Basketball in the Fight Against Breast Cancer 2Health News:Maricopa Community Colleges Add $7.3 Billion to Local Economy Annually 2Health News:Maricopa Community Colleges Add $7.3 Billion to Local Economy Annually 3
... EDAP TMS S.A. (Nasdaq:,EDAP) the global leader ... announces that it has entered into a securities ... buyers,("Investors") pursuant to which the Investors will purchase ... EDAP,s ordinary shares,which will be delivered in the ...
... BOSTON, Oct. 30 Portrayals of bipolar,disorder seem ... news, in movies, and,on television. The November 2007 ... and misunderstandings about this condition., Bipolar disorder ... confused,with other mental illnesses. Because mania is the ...
... was,released today by the Center for Consumer Freedom:, ... the results of a five-year examination of various causes ... expected to recommend,limiting human intake of specific foods, including ... for Consumer Freedom is,available to discuss the implications of ...
... Down syndrome infants on treadmill training for just minutes ... or five months earlier than with only traditional physical ... says. , The study also suggests that infants who ... , Getting infants walking is critical because so ...
... children with dyslexia struggle to read because their ... according to a brain-imaging study published this month ... October 16). The study found that sound training ... correcting the sound processing problem and improving reading. ...
... California will simultaneously open their doors Wednesday to ... cover the,festivities, SAN FRANCISCO, Oct. 30 It,s ... Nurse administrators don,t often,see miniature witches and 3-foot-tall bumblebees, ... 80-year-young ballerinas! But at more,than 150 nursing homes in ...
Cached Medicine News:Health News:EDAP TMS S.A. Announces $20 Million Placement to Fund US Clinical Studies 2Health News:EDAP TMS S.A. Announces $20 Million Placement to Fund US Clinical Studies 3Health News:Misconceptions About Bipolar Disorder Explained, From the Harvard Health Letter 2Health News:Treadmill training helps Down syndrome babies walk months earlier 2Health News:Sound training rewires dyslexic children's brains for reading 2Health News:Sound training rewires dyslexic children's brains for reading 3Health News:Halloween Events in the Bay Area Bring Young and Old Together for a Ghoulish Good Time 2
... The Benchtop Fume Hood is an economical ... in which a number of fume hoods ... junior colleges and universities. Features include a ... with rounded inside corners for easy cleaning. ...
These handy dispensers save space and organize gloves in labs and next to hand washers. Clear acrylic. Many other sizes and custom configurations available....
... most convenient for sectioning of specimens in ... Specimen rise is automatic and accurate with ... microns in increments of 0.5 microns. ... Products, Vibratomes Freezing Stages ...
... MNL 440601 Small Sledge Microtome is ideal for ... or skin specimens. Specimen rise is automatic ... 30 microns in increments of 2 microns. ... Stages.,Other Associated Products, Vibratomes Freezing Stages ...
Medicine Products: